Patents by Inventor Kenneth Mendoza

Kenneth Mendoza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment for anxiety
    Patent number: 8536129
    Abstract: The invention provides methods of treating or effecting prophylaxis of a patient having or at risk of developing symptoms of anxiety in which an effective regime of an agent that inhibits specific binding of PSD95 to an NMDA receptor is administered to a patient.
    Type: Grant
    Filed: July 19, 2011
    Date of Patent: September 17, 2013
    Assignee: NoNO Inc.
    Inventors: Andrew Tasker, Tracy Doucette, Michael Tymianski, Kenneth Mendoza, Michael P. Belmares, David Garman, Peter S. Lu
  • TREATMENT FOR ANXIETY
    Publication number: 20120083449
    Abstract: The invention provides methods of treating or effecting prophylaxis of a patient having or at risk of developing symptoms of anxiety in which an effective regime of an agent that inhibits specific binding of PSD95 to an NMDA receptor is administered to a patient.
    Type: Application
    Filed: July 19, 2011
    Publication date: April 5, 2012
    Applicants: Arbor Vita Corporation, NoNO Inc.
    Inventors: Andrew Tasker, Tracy Doucette, Michael Tymianski, Kenneth Mendoza, Michael P. Belmares, David Garman, Peter S. Lu
  • Treatment for anxiety
    Patent number: 8008253
    Abstract: The invention provides methods of treating or effecting prophylaxis of a patient having or at risk of developing symptoms of anxiety in which an effective regime of an agent that inhibits specific binding of PSD95 to an NMDA receptor is administered to a patient.
    Type: Grant
    Filed: July 1, 2008
    Date of Patent: August 30, 2011
    Inventors: Andrew Tasker, Tracy Doucette, Michael Tymianski, Kenneth Mendoza, Michael P. Belmares, David Garman, Peter S. Lu
  • Treatment for Anxiety
    Publication number: 20090036376
    Abstract: The invention provides methods of treating or effecting prophylaxis of a patient having or at risk of developing symptoms of anxiety in which an effective regime of an agent that inhibits specific binding of PSD95 to an NMDA receptor is administered to a patient.
    Type: Application
    Filed: July 1, 2008
    Publication date: February 5, 2009
    Applicants: NoNO Inc., Arbor Vita Corporation
    Inventors: Andrew Tasker, Tracy Doucette, Michael Tymianski, Kenneth Mendoza, Michael P. Belmares, David Garman, Peter S. Lu